The global anterior uveitis treatment market is growing at a significant CAGR of around 6.1% during the forecast period (2020-2026). Anterior uveitis is referred to the occurrence of inflammation in the middle layer of the eye. The early treatment of anterior uveitis is necessary, as it can sometimes leads to permanent loss of vision (blindness) due to the development of cataract, glaucoma, or retinal edema. The increasing prevalence of eye-related disorders has raised the demand for anterior uveitis treatment across the globe. According to the World Health Organization (WHO), in 2019, around 2.2 billion people from globally have been suffering from one or the other kind of visual impairment. Most of these vision impairments are due to cataract (65.2 million) and uncorrected refractive errors (123.7 million). In addition, there are several other causes of visual impairment, such as occurrence of glaucoma (6.9 million), diabetic retinopathy (3 million), unaddressed presbyopia (826 million), corneal opacity (4.2 million), and trachoma (2 million). Such large population base having some kind of eye-related disorders (associated with anterior uveitis) is expected to drive the market growth during the forecast period.

Moreover, there are several other pivotal factors that are driving the global anterior uveitis treatment market, which includes growing government initiatives to aware population and provide better healthcare facilities to create enormous opportunities for the anterior uveitis treatment market in the emerging nations, such as India, China, and Brazil. An increasing number of hospitals and ophthalmic clinics are providing significant growth opportunities for the anterior uveitis treatment market. This increasing prevalence of cataract creates enormous opportunities for the companies developing treatment solutions for the anterior uveitis to expand their market in such emerging economies across the globe.   

Segmental Outlook  

The anterior uveitis treatment market is classified on the basis of therapeutics into corticosteroids, anti-inflammatory agents, cycloplegics, antimetabolites, biologics, and others. Among these therapeutics, the corticosteroids contribute significantly in the growth of the anterior uveitis treatment market and is estimated to project a considerable CAGR during the forecast period. The major factors that augment the demand for corticosteroids in the treatment of anterior uveitis includes its increasing use in the form of systematic therapy. Moreover, the corticosteroids are used in the ocular implants, and therefore, considered as a first line treatment in ophthalmic treatment procedures.

Global Anterior uveitis treatment Market Share by Therapeutics, 2019 (%)

Regional Outlook 

The global anterior uveitis treatment market is classified on the basis of geography, which includes North America, Europe, Asia-Pacific, and Rest of the World. North America holds a significant share in the global anterior uveitis treatment market. The US plays the critical role in geographic contribution of North America in global anterior uveitis treatment market, attributed to the significant presence of market players in the region, particularly in the US. The US is a home for major anterior uveitis treatment companies including AbbVie Inc., Alimera Sciences, Inc., and Santen Pharmaceutical Co., Ltd. Moreover, as the US substantially aims at the development of advanced healthcare infrastructure and public health, several organizations in the region have taken initiative for curbing the rising eye surgical procedures. For instance, ‘Fight For Sight’ in the US is a non-profit organization that provides funding for medical research in vision and ophthalmology. It provides funding and acknowledgment to promising scientists early in their eye research careers before they are eligible for government support from the National Institutes of Health.

Global Anterior uveitis treatment Market Growth, by Region 2020-2026

Asia-Pacific is expected to propel with a considerable growth rate in the global market

Asia-Pacific is estimated to project a considerable CAGR in the global anterior uveitis treatment market. Countries in Asia-Pacific that are contributing to the market growth include China, India, and Japan. The market is driven by the increasing government initiatives and the rising cataract-removal surgeries. As per the World Health Organization, China had the largest number with 8 million blind and 75 million visually impaired individuals. A cataract is a major cause responsible for blindness in people followed by glaucoma, presbyopia, and others. The Chinese Ministry of Health has reported that 45% of China’s 2,400 country’s hospitals do not offer cataract surgery services and most rural residents are unable to afford surgery in urban centers. On this account various projects were intended, such as Project Vision, a non-governmental organization, to build a sustainable model to reduce cataract blindness in rural China.

Market Players Outlook

The key players in the anterior uveitis treatment market are contributing significantly by providing advanced technology-based products and through expanding their geographical presence across the globe. The key players operating in the global anterior uveitis treatment market include AbbVie Inc., Alimera Sciences, Inc., Santen Pharmaceutical Co., Ltd., Allergan PLC, Cadila Pharmaceuticals Ltd., and EyePoint Pharmaceuticals, Inc. These market players adopt various strategies such as product launch, partnerships, collaborations, merger, and acquisitions to sustain a strong position in the market. 

The Report Covers

• Market value data analysis of 2019 and forecast to 2026.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global anterior uveitis treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.